Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Stevens

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
When Future Change Matters: Modeling Future Price and Diffusion in Health Technology Assessments of Medical DevicesSabine E Grimm, Simon Dixon, John W Stevens
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2018
Estimating Future Health Technology Diffusion Using Expert Beliefs Calibrated to an Established Diffusion ModelSabine E Grimm, John W Stevens, Simon Dixon
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 7, 2017
Assessing the Expected Value of Research Studies in Reducing Uncertainty and Improving Implementation DynamicsSabine E Grimm, Simon Dixon, John W Stevens
Research Synthesis Methods|October 27, 2017
A review of methods for comparing treatments evaluated in studies that form disconnected networks of evidenceJohn W Stevens, Christine Fletcher, Gerald Downey, et al.
Pharmaceutical Statistics|November 4, 2006
Bayesian decision procedures for binary and continuous bivariate dose-escalation studiesYinghui Zhou, John Whitehead, Elisa Bonvini, et al.
Pharmacoeconomics|April 12, 2013
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisalJonathan Tosh, Rachel Archer, Sarah Davis, et al.
Pharmaceutical Statistics|October 24, 2008
Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritisRichard M Nixon, Nick Bansback, John W Stevens, et al.
Pharmacoeconomics|August 3, 2016
Vedolizumab for Treating Moderately to Severely Active Crohn's Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachid Rafia, Alison Scope, Sue Harnan, et al.
Pharmacoeconomics|April 9, 2015
Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMatt Stevenson, Abdullah Pandor, John W Stevens, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2020
Reply to Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with careDaniel Horner, John W Stevens, Abdullah Pandor, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
When Future Change Matters: Modeling Future Price and Diffusion in Health Technology Assessments of Medical DevicesSabine E Grimm, Simon Dixon, John W Stevens
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2018
Estimating Future Health Technology Diffusion Using Expert Beliefs Calibrated to an Established Diffusion ModelSabine E Grimm, John W Stevens, Simon Dixon
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 7, 2017
Assessing the Expected Value of Research Studies in Reducing Uncertainty and Improving Implementation DynamicsSabine E Grimm, Simon Dixon, John W Stevens
Research Synthesis Methods|October 27, 2017
A review of methods for comparing treatments evaluated in studies that form disconnected networks of evidenceJohn W Stevens, Christine Fletcher, Gerald Downey, et al.
Pharmaceutical Statistics|November 4, 2006
Bayesian decision procedures for binary and continuous bivariate dose-escalation studiesYinghui Zhou, John Whitehead, Elisa Bonvini, et al.
Pharmacoeconomics|April 12, 2013
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisalJonathan Tosh, Rachel Archer, Sarah Davis, et al.
Pharmaceutical Statistics|October 24, 2008
Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritisRichard M Nixon, Nick Bansback, John W Stevens, et al.
Pharmacoeconomics|August 3, 2016
Vedolizumab for Treating Moderately to Severely Active Crohn's Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachid Rafia, Alison Scope, Sue Harnan, et al.
Pharmacoeconomics|April 9, 2015
Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMatt Stevenson, Abdullah Pandor, John W Stevens, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2020
Reply to Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with careDaniel Horner, John W Stevens, Abdullah Pandor, et al.
Pageof 5